Grants and Contracts Details
Description
Addressing genetic tractability and species-specific infection biology in Chlamydia
pneumoniae.
ABSTRACT
Chlamydia species represent a paradigm for understanding successful obligate intracellular
parasitism. While C. trachomatis and C. pneumoniae are both prevalent human pathogens, C.
pneumoniae respiratory infections are likely most common. Acute C. pneumoniae infections
manifest as community acquired pneumonia, bronchitis, and sinusitis while additional
inflammatory sequelae are associated with chronic infection. Advances in genetic tractability
have facilitated considerable progress in characterizing C. trachomatis pathogenesis.
Unfortunately, similar progress has lagged for C. pneumoniae, leading to a paucity in details
regarding molecular mechanisms of infection and precluding informative approaches leveraging
comparative studies. To overcome this barrier, we will engineer plasmid systems enabling allelic
replacement and ectopic gene expression for C. pneumoniae. These new technologies will be
applied in proof-of-principle studies to delineate comparative mechanisms employed by C.
trachomatis and C. pneumoniae to manipulate host cell biology during processes equally
important to both species. At the end of these studies, we will have established new approaches
that will benefit the entire Chlamydia research community and advance the understanding of
how chlamydial species have evolved to accomplish common developmental requirements.
| Status | Finished |
|---|---|
| Effective start/end date | 11/7/22 → 6/30/25 |
Funding
- National Institute of Allergy and Infectious Diseases: $420,750.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.